BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3261246)

  • 1. Autoantibody production is associated with polyclonal B cell activation in autoimmune mice which express the lpr or gld genes.
    Ishigatsubo Y; Steinberg AD; Klinman DM
    Eur J Immunol; 1988 Jul; 18(7):1089-93. PubMed ID: 3261246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
    Giese T; Davidson WF
    J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice.
    Klinman DM; Eisenberg RA; Steinberg AD
    J Immunol; 1990 Jan; 144(2):506-11. PubMed ID: 2295800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition and maturation of expressed B cell repertoires in normal and autoimmune mice.
    Klinman DM; Ishigatsubo Y; Steinberg AD
    J Immunol; 1988 Aug; 141(3):801-6. PubMed ID: 3260912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease.
    Klinman DM
    J Clin Invest; 1990 Oct; 86(4):1249-54. PubMed ID: 2212009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infusion of normal bone marrow partially corrects the gld T-cell defect. Evidence for an intrinsic and extrinsic role for Fas ligand.
    Sobel ES; Kakkanaiah VN; Kakkanaiah M; Cohen PL; Eisenberg RA
    J Immunol; 1995 Jan; 154(1):459-64. PubMed ID: 7527822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of B-cell abnormalities in lupus-prone (NZB x NZW)F1 mice by normal bone marrow-derived B-lineage cells.
    Shao DZ; Yamada S; Hirayama F; Hirano H; Ono S; Hamaoka T
    Immunology; 1995 May; 85(1):16-25. PubMed ID: 7635516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.
    Liu W; Szalai A; Zhao L; Liu D; Martin F; Kimberly RP; Zhou T; Carter RH
    Arthritis Rheum; 2004 Jun; 50(6):1884-96. PubMed ID: 15188365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice.
    Reap EA; Leslie D; Abrahams M; Eisenberg RA; Cohen PL
    J Immunol; 1995 Jan; 154(2):936-43. PubMed ID: 7529292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on expression and function of Eta-1(early T lymphocyte activation-1) in autoimmune prone MRL/Mp-lpr/lpr mice].
    Mori K
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):708-17. PubMed ID: 7525433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities in B cell repertoire development between autoimmune and aging normal mice.
    Klinman DM
    J Immunol; 1992 Mar; 148(5):1353-8. PubMed ID: 1538120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids.
    al-Balaghi S; Möller E; Möller G; Abedi-Valugerdi M
    Eur J Immunol; 1996 Jul; 26(7):1519-26. PubMed ID: 8766555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lpr T cells are necessary for autoantibody production in lpr mice.
    Sobel ES; Cohen PL; Eisenberg RA
    J Immunol; 1993 May; 150(9):4160-7. PubMed ID: 8473754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in vitro and in vivo mitogenic and polyclonal antibody and autoantibody responses to peptidoglycan, LPS, protein A, PWM, PHA and Con A in normal and autoimmune mice.
    Dziarski R
    J Clin Lab Immunol; 1985 Feb; 16(2):93-109. PubMed ID: 3886911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma.
    Klinman DM
    J Immunol; 1990 Apr; 144(7):2529-34. PubMed ID: 2108205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle analysis of lymphocyte activation in normal and autoimmune strains of mice.
    Raveche ES; Steinberg AD; DeFranco AL; Tjio JH
    J Immunol; 1982 Sep; 129(3):1219-26. PubMed ID: 6125541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
    Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
    J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses of B cells from autoimmune mice to IL-5.
    Umland SP; Go NF; Cupp JE; Howard M
    J Immunol; 1989 Mar; 142(5):1528-35. PubMed ID: 2783944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.